Engitix expands collaboration with Takeda to include therapeutics for fibrostenotic IBD April 13, 2022
Adenosine A2B receptor targeting protects against acetaminophen-induced hepatotoxicity March 31, 2022
Sosei Heptares' GLP-1/2 agonist HTL-0030023 shows promising results for treating NAFLD and NASH March 28, 2022